Navigation Links
Pioneer(R) Surgical Technology Announces Market Release of FortrOss(TM), a Next Generation Bone Void Filler

Pioneer's First In-House Biologic Product to Debut at NASS

GREENVILLE, N.C. and WOBURN, Mass., Oct. 14 /PRNewswire/ -- Pioneer Surgical Technology, Inc. today announced the U.S. market release of their FortrOss bone graft substitute. The novel biologic will make its public debut at the 23rd Annual Meeting of the North American Spine Society (NASS) in Toronto, Canada. The FortrOss bone void filler, utilizing the power of nanotechnology for orthopaedic applications, is a scaffold for the in-growth of new bone when superior bone regeneration is required.

Pioneer's CEO and Chairman of the Board, Matthew N. Songer, MD, MBA says, "The Pioneer Orthobiologics team has reached a huge milestone with the release of the FortrOss. This is the culmination of over 10 years work by each of the two companies, Encelle(TM) Inc. and Angstrom(TM) Medica, Inc. that were acquired by Pioneer in 2007."

The FortrOss bone void filler combines the nanotechnology of nanOss(TM) hydroxyapatite with the bone growth promotion of E-Matrix(TM) scaffold. The FortrOss bone void filler is the most advanced on the market. The FortrOss osteoconductive matrix utilizes Pioneer's nanOss(TM) technology and is designed to mimic the nanostructures inherent in bone tissue.

According to Dr. Edward Ahn, Vice President of Biomaterials at Pioneer states, "Because the nanOss hydroxyapatite in FortrOss resembles the size, shape, and chemistry of native bone, bone tissue has a great affinity for nanOss and recognizes it as native tissue. This mimicry of native bone makes nanOss superior to other calcium phosphates on the market."

The combined nanotechnology-based osteoconduction and osteopromotive E- Matrix scaffold of FortrOss bone void filler positions Pioneer to impact significantly the dynamic field of bone repair.

About Pioneer Surgical Technology

Pioneer Surgical Technology, Inc., headquartered in Marquette, Michigan, is a dynamic medical device firm with a full line of cutting-edge motion preservation devices, either available commercially in Europe or under clinical evaluation in the U.S. Pioneer's signature articulating P3(TM) Technology - Pioneer PEEK-on-PEEK, in its NuBac(TM) disc arthroplasty system, BacJac(TM) interspinous decompression system, and NuNec(TM) artificial cervical disc, is the most technologically advanced in the industry. Currently, Pioneer offers a diverse portfolio of next generation spinal fusion devices. Pioneer's focus on innovation has resulted in over 100 U.S. and Foreign patents with numerous patents pending. The company established a Biologics Division following two acquisitions in 2007. Pioneer Orthobiologics is developing a rich pipeline of products indicated for a variety of spinal and orthopaedic applications. Pioneer focuses on developing products which are easier and faster for the surgeon, cost effective for the health care system, and provide better patient outcomes.

SOURCE Pioneer Surgical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. DuPont Obtains Biotechnology Endorsement for Pioneer(R) Brand Products
2. Pioneer(R) Surgical Technology, Inc. Announces the Market Launch of the SlimFuse(TM) Anterior Cervical Plate System
3. Pioneer(R) Brand Soybeans From DuPont Deliver Step-Change in Soybean Yields
4. Pioneer(R) Surgical Technology Announces First Human Implants of its NuNec(TM) Cervical Arthroplasty Device
5. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
6. CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure
7. Reliant Technologies Announces FDA 510(K) Clearance of New Handpieces for Skin Resurfacing and Surgical Applications
8. New Opportunities in X-Ray Based Surgical Navigation With Ziehm NaviPort 3D
9. Sound Surgical Technologies Welcomes Dr. Mark Schafer as New Chief Technology Officer and Vice President of Research & Development
10. Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market
11. Baxter Announces Licensing Agreement for Innocolls Gentamicin Surgical Implant in the United States
Post Your Comments:
(Date:12/1/2015)... , Dec. 1, 2015  The Minnesota High ... of the 2015 Tekne Award in the Small and ... at the Minneapolis Convention Center, ... played a significant role in developing new technologies that ... around the world. Clostridium difficile infection ...
(Date:12/1/2015)... ADDISON, Texas (PRWEB) , ... ... ... International , a leading relationship marketing company specializing in scientifically backed, age-defying ... magazine’s January 2016 issue, which highlights the exponential success and unrivaled opportunities ...
(Date:12/1/2015)... ... , ... Matthew “Tex” VerMilyea, PhD, HCLD, has joined Texas Fertility Center as ... lab procedures as well as continue his research efforts into the emerging technologies of ... New Zealand to bring home a High Complexity Clinical Laboratory Director named Tex,” says ...
(Date:11/30/2015)... ... ... Global Stem Cells Group announced the opening of a new core patient care hub ... northern Chile. The facilities are part of GSCG’s expansion efforts in Latin America. , ... cell medicine to patients from around the world. , The clinics will be headed by ...
Breaking Biology Technology:
(Date:11/20/2015)... Connecticut , November 20, 2015 ... authentication company focused on the growing mobile commerce market ... CEO, Gino Pereira , was recently interviewed on ... interview will air on this weekend on Bloomberg ... Latin America . --> NXTD ) ("NXT-ID" ...
(Date:11/17/2015)... Paris from 17 th until 19 ... from 17 th until 19 th November 2015. ... invented the first combined scanner in the world which scans ... now two different scanners were required: one for passports and ... the same surface. This innovation is an ideal solution for ...
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever that ... muscular dystrophy (DMD) has provided a new lead for ... Hospital, the Broad Institute of MIT and Harvard and ... . Cell, pinpoints a ... "escape" the disease,s effects. The Boston Children,s lab of ...
Breaking Biology News(10 mins):